Showing 1531-1540 of 9707 results for "".
The Next Big Thing: Aesthetics in 2016
https://practicaldermatology.com/topics/practice-management/the-next-big-thing-aesthetics-in-2016/21035/Industry leaders share their predictions for what we will be talking about this year in aesthetic dermatology.Enhancing Treatment Adherence
https://practicaldermatology.com/topics/practice-management/enhancing-treatment-adherence/21083/Devising a strategy to engage patients in their treatment regimen for better results.Enstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial lOnline Marketing Tips
https://practicaldermatology.com/topics/practice-management/online-marketing-tips/18690/Risa Goldman Luksa tells you what you need to know to ensure a solid foundation for your online marketing program.Color Your World
https://practicaldermatology.com/topics/practice-management/color-your-world/18833/The colors you use in your office and the style of your space-and your staff outfits-can all influence the perception of you and your practice. Heidi Waldorf, MD tells you how to give your space the attention it needs.Why Consider Lasers?
https://practicaldermatology.com/topics/practice-management/why-consider-lasers/18863/Should younger dermatologists add devices to their practice? Laser expert Eric Bernstein, MD talks about the decision to embrace technology and explains how it can mold the future of those who have a passion for lasers and other energy-based devices. Watch other PD Asks videos with Eric BernsteinWeighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.Take 5: Innovations in Aesthetic Treatments
https://practicaldermatology.com/columns/take-5/take-5-innovations-in-aesthetic-treatments/21746/Five new or emerging products may expand skin rejuvenation options.An Update on At-Home UVB Phototherapy
https://practicaldermatology.com/topics/general-topics/an-update-on-at-home-uvb-phototherapy/21786/At-home options increase accessibility to phototherapy, which is effective and generally safe for psoriasis management.Non-genital Warts: A Review of Current Treatments
https://practicaldermatology.com/topics/general-topics/non-genital-warts-a-review-of-current-treatments/21884/When determining which treatment modality to choose for non-genital warts, there are several factors to consider, including the convenience of the treatment, patient discomfort, location of warts, and potential side effects.